Clinicogenomic Analysis of FGFR2-Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib.
- DOI
- 10.1158/2159-8290.cd-20-0766
- Published
- 2021 Feb
- Container
- Cancer discovery
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/2159-8290.cd-20-0766,
title = {Clinicogenomic Analysis of FGFR2-Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib.},
author = {Silverman IM and Hollebecque A and Friboulet L and Owens S and Newton RC and Zhen H and Féliz L and Zecchetto C and Melisi D and Burn TC},
year = {2021},
journal = {Cancer discovery},
doi = {10.1158/2159-8290.cd-20-0766},
url = {https://doi.org/10.1158/2159-8290.cd-20-0766}
}RIS
TY - JOUR TI - Clinicogenomic Analysis of FGFR2-Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib. AU - Silverman IM AU - Hollebecque A AU - Friboulet L AU - Owens S AU - Newton RC AU - Zhen H AU - Féliz L AU - Zecchetto C AU - Melisi D AU - Burn TC PY - 2021 JO - Cancer discovery DO - 10.1158/2159-8290.cd-20-0766 UR - https://doi.org/10.1158/2159-8290.cd-20-0766 ER -
APA
IM, S., A, H., L, F., S, O., RC, N., H, Z., L, F., C, Z., D, M., & TC, B. (2021). Clinicogenomic Analysis of FGFR2-Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib.. Cancer discovery. https://doi.org/10.1158/2159-8290.cd-20-0766
Source records
- pubmed · retrieved 2026-11-10T10:04:33.661Z